MedTrace Logo

Registry on Luma Vision's VERAFEYE System (ENLIgHT)

NCT06293430 · Status: NOT_YET_RECRUITING · Type: OBSERVATIONAL · Enrollment: 50

Last updated 2026-05-07

No results posted yet for this study

Summary

The objective of the study is to compile real-world data on the use of the VERAFEYE System in standard of care atrial fibrillation (AF) ablation procedures and left atrial appendage closure (LAAC) procedures.

Conditions

Interventions

DEVICE

VERAFEYE System

VERAFEYE system guidance will be used on all patients undergoing AF ablation and/or LAAC procedures.

Sponsors & Collaborators

  • LUMA Vision Ltd.

    lead INDUSTRY

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2026-12-15
Primary Completion
2027-08-15
Completion
2027-08-15
FDA Device
Yes

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06293430 on ClinicalTrials.gov